Related Experiment Video

Updated: May 25, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Recommendations for the use of influenza vaccine in pediatrics

Susanna Esposito1, Valentina Montinaro, Samantha Bosis

  • 1Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. susanna.esposito@unimi.it

Human Vaccines & Immunotherapeutics
|January 19, 2012
PubMed

Insights

Pediatric influenza vaccination guidelines conflict due to varying disease impact and vaccine efficacy data. Further research on healthy and high-risk children is needed to improve vaccine coverage.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Annual pediatric influenza vaccination recommendations are issued globally.
  • Conflicting guidelines exist regarding influenza's importance and vaccine efficacy in children.
  • Inconsistent definitions of at-risk populations hinder accurate vaccination strategies.

Purpose of the Study:

  • To highlight limitations in current pediatric influenza vaccination recommendations.
  • To emphasize the need for improved definitions of at-risk populations.
  • To advocate for further research to enhance vaccine coverage.

Main Methods:

  • Analysis of existing pediatric influenza vaccination guidelines.
  • Evaluation of discrepancies in disease burden and vaccine efficacy data.
  • Identification of gaps in research concerning healthy and high-risk pediatric populations.

Main Results:

  • Significant variations exist in recommended vaccine targets for pediatric influenza.
  • Definitions of children at risk for influenza complications are often imprecise.
  • Current data is insufficient to optimize vaccination strategies for all pediatric groups.

Conclusions:

  • Further studies are essential to address limitations in pediatric influenza vaccination.
  • Comprehensive research on disease burden and vaccine efficacy in diverse pediatric groups is required.
  • Improved evidence will lead to better-defined recommendations and increased vaccination coverage.

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Expression and Purification of Virus-like Particles for Vaccination06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...